Skip to NavigationSkip to content

Novo Nordisk to offer US patient’s in immediate need free insulin

Published on 03/01/20 at 12:39pm

Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices.

Novo has said that patients with a prescription can get the free insulin, in a supply of up to three vials or two packs of pens of its insulin. But after this they have to find a longer-term solution.

This follows a move back in September where they allowed their US patients to buy three vials, or two packs of pens, of its analogue insulins for $99.

This move by Novo comes following the announcement that multiple drug companies were raising the prices on 200 drugs. Novo itself raised the price of insulin, branded Novolog, in January 2019 and over the last decade the average price has increased drastically.

At the start of 2009, Novo Nordisk’s Novolog costs almost $93, but by the end of 2019 it cost $290 for a 10mm vial.

The skyrocketing price of insulin has led to many rationing it. While Novo’s announcement seeks to offer a short term solution, it is clear it has been part of the problem in the continual rise in insulin prices. Presidential candidate Bernie Sanders led a caravan of type 1 diabetes on bus to Canada, back in July, to highlight the rising cost of prescription drugs in the US calling it a “national embarrassment.”

Conor Kavanagh

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches